Back to search

Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2a

Data up to Jan 2025

Published1989
Citations444
References26

Total Citations Per Year

Abstract

References (26)

Angiogenic Factors

1987 • 3,702 citations

Clinical toxicity of interferons in cancer patients: a review.

1986 • 601 citations

Inhibition of Cell Motility by Interferon

1980 • 331 citations

Recombinant Alpha-2 Interferon Therapy for Kaposi's Sarcoma Associated with the Acquired Immunodeficiency Syndrome

1984 • 329 citations

Inhibition of endothelial cell proliferation by gamma-interferon.

1987 • 292 citations

Inhibition of angiogenesis through modulation of collagen metabolism.

1988 • 240 citations

Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon.

1986 • 209 citations

Gamma-interferon inhibits collagen synthesis in vivo in the mouse.

1987 • 181 citations

Interferon effects on microfilament organization cellular fibronectin distribution, and cell motility in human fibroblasts

1980 • 178 citations

DIFFUSE NEONATAL HEMANGIOMATOSIS

1970 • 166 citations

Capillary haemangiomatosis of the lungs

1978 • 153 citations

Familial Pulmonary Capillary Hemangiomatosis Resulting in Primary Pulmonary Hypertension

1988 • 135 citations

Pulmonary capillary hemangiomatosis

1986 • 127 citations

Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferon.

1985 • 101 citations

The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events

1985 • 84 citations

Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon.

1985 • 63 citations

IMMUNOREGULATORY ACTION OF TYPE I INTERFERON IN THE MOUSE*

1980 • 55 citations

Angiomatosis (hamartomatous hem-lymphangiomatosis). Report of a case with diffuse involvement.

1961 • 55 citations

ANGIOMATOSIS (HAMARTOMATOUS HEM-LYMPHANGIOMATOSIS)

1961 • 49 citations

Interferon enhances prostacyclin production by cultured vascular endothelial cells.

1984 • 43 citations

Cultured human endothelial cells treated with recombinant leukocyte A interferon. Tubuloreticular inclusion formation, antiproliferative effect, and 2',5' oligoadenylate synthetase induction.

1988 • 42 citations

Thoracic Hemangiomatosis Masquerading as Interstitial Lung Disease

1988 • 34 citations

Pulmonary capillary haemangiomatosis.

1983 • 34 citations

Diffuse Pulmonary Hemangiomatosis

1978 • 30 citations

OPENING REMARKS

1980 • 26 citations

Pulmonary veno-occlusive disease

1977 • 19 citations

Cited By (0)

Loading...
Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2a (1989) – New England Journal of Medicine | Metascience Observatory Explorer